The gut microbiota is an integral component of the colorectal cancer (CRC) microenvironment and is intimately associated with CRC initiation, progression, and therapeutic outcomes. We reviewed recent advancements in utilizing nanotechnology for modulating gut microbiota, discussing strategies and the mechanisms underlying their design. For future nanomedicine design, we propose a 5I principle for individualized nanomedicine in CRC management.
The challenge and opportunity of gut microbiota‐targeted nanomedicine for colorectal cancer therapy / Wei, Yaohua; Shen, Feng; Song, Huidong; Zhao, Ruifang; Feng, Weiyue; Pan, Yue; Li, Xiaobo; Yu, Huanling; Familiari, Giuseppe; Relucenti, Michela; Aschner, Michael; Shi, Hanping; Chen, Rui; Nie, Guangjun; Chen, Hanqing. - In: SEMICONDUCTORS AND SEMIMETALS. - ISSN 0080-8784. - 3:4(2024), pp. 1-7. [10.1002/imt2.213]
The challenge and opportunity of gut microbiota‐targeted nanomedicine for colorectal cancer therapy
Familiari, Giuseppe;Relucenti, Michela;
2024
Abstract
The gut microbiota is an integral component of the colorectal cancer (CRC) microenvironment and is intimately associated with CRC initiation, progression, and therapeutic outcomes. We reviewed recent advancements in utilizing nanotechnology for modulating gut microbiota, discussing strategies and the mechanisms underlying their design. For future nanomedicine design, we propose a 5I principle for individualized nanomedicine in CRC management.| File | Dimensione | Formato | |
|---|---|---|---|
|
Wei_challenge-opportunity_2024.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
754.48 kB
Formato
Adobe PDF
|
754.48 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
